The upregulated expression of FUT8 has been reported in several cancers, including breast cancer, lung cancer, prostate cancer, hepatocellular carcinoma, colorectal cancer, and melanoma, demonstrating that FUT8 is involved in biological tumor characteristics and patient outcomes13–17. Here, FUT8 is linked to breast carcinoma.